Skip to main content
. 2023 Apr 1;12(7):2638. doi: 10.3390/jcm12072638

Table 3.

Adverse events. Data are presented as n (%).

FES (n = 94) Control (n = 96) p-Value
Any adverse event 7 (7) 2 (2) 0.10
Adverse events related to treatment 0 0 -
Any serious adverse event 1 (1) 0 0.49